healthcare News
NewAmsterdam cash runway supports path to key 2026 regulatory decisions
$729M war chest funds operations through obicetrapib cardiovascular outcomes trial readout as EMA approval expected second half of 2026
Tactile Systems surges to 52-week high on earnings beat
Medical device company tops estimates with 21% revenue growth and expands digital capabilities through LymphaTech acquisition
Veradigm delisted to OTC as cash tumbles 59% amid SEC probe
Healthcare IT company projects flat revenue for 2025 while grappling with regulatory scrutiny
Glaukos plunges 6% on EPS miss despite revenue surge
Non-cash impairment charge offsets 36% revenue growth in glaucoma treatment business
J&J wins FDA approval for monthly lung cancer therapy Rybrevant
New dosing schedule offers convenience advantage over AstraZeneca's Tagrisso in $16B EGFR market
Outlook Therapeutics slides on Q1 loss, FDA rejection raises cash concerns
Biotech reports negative revenue as UK returns bite, with $8.7M cash runway as it seeks fourth regulatory path for eye drug
NeuroOne beats Q1 estimates, raises 2026 outlook on OneRF momentum
Medical device company reports stronger-than-expected earnings as trigeminal nerve ablation system gains traction
Krystal Biotech surges after beating Q4 estimates
Gene therapy company reports 34% full-year revenue growth with strong cash position and key FDA designations